Skip to main content
Premium Trial:

Request an Annual Quote

AssureRx Secures $8M Credit Facility

NEW YORK (GenomeWeb News) – AssureRx today announced it has secured an $8 million term and revolving credit facility, which it will use to increase adoption of its GeneSightRx test.

The facility was secured through the Mason, Ohio-based firm's new banking partner, Silicon Valley Bank. In addition to ramping up GeneSightRx, AssureRx said that the financing will be used to finance new products anticipated to launch this year.

It also plans to "substantially" increase the size of its sales force in 2012.

GeneSightRx, launched in 2009, is a pharmacogenomic test for helping clinicians determine which psychiatric drugs may be most effective for a specific patient. The company received certification from New York last week for its laboratory, and can now analyze DNA analysis for pharmacogenomic testing in all 50 states.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.